SP4 and non-small cell lung carcinoma: Tat-SP4 also synergized with erlotinib to potently inhibit the proliferation of non-small-cell lung cancer cell lines A549 and H1975 by degrading the over-expressed EGFR and inducing non-apoptotic cell death [28].